Trials / Unknown
UnknownNCT05477966
A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 900 (estimated)
- Sponsor
- Jae-Joon Yim · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to compare how accurately the Xpert MTB/RIF assay Ct value at diagnosis and the AI-based tuberculosis activity score predict the treatment outcome of rifampin-susceptible pulmonary tuberculosis patients. As a retrospective observational study, data from patients diagnosed with rifampin susceptible pulmonary tuberculosis through the Xpert MTB/RIF assay performed on sputum in 2019 at the participating institutions will be analyzed (up to 900 people).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medical records review | The clinical characteristics at the time of diagnosis of rifampin-susceptible pulmonary tuberculosis patients, the Xpert MTB/RIF assay Ct value, the tuberculosis activity score based on AI of the chest image, and treatment results will be collected retrospectively through medical records. |
Timeline
- Start date
- 2022-07-18
- Primary completion
- 2023-07-18
- Completion
- 2023-07-18
- First posted
- 2022-07-28
- Last updated
- 2022-07-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05477966. Inclusion in this directory is not an endorsement.